Igenica Lands $24,000,000 Series B Financing Round

  • Feed Type
  • Date
    6/11/2010
  • Company Name
    Igenica
  • Mailing Address
    1700 Owens St San Francisco, CA 94158
  • Company Description
    The company operates as a drug development company for cancer treatment.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $24,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This financing will allow us to expand and accelerate our drug discovery and development efforts significantly.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    5AM Ventures
  • Venture Investor
    OrbiMed

By posting a comment, you agree to our terms and conditions.